Cargando…

Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation

BACKGROUND: Vessels that encapsulate tumor clusters (VETC) is a novel vascular pattern seen on hepatocellular carcinoma (HCC) histology which has been shown to independently predict tumor recurrence and survival after liver resection. Its prognostic value in HCC patients receiving liver transplantat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dennis, Claude, Prince, David S., Moayed-Alaei, Leila, Remash, Devika, Carr-Boyd, Emily, Bowen, David G., Strasser, Simone I., Crawford, Michael, Pulitano, Carlo, Kench, James, McCaughan, Geoffrey W., McKenzie, Catriona, Liu, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643778/
https://www.ncbi.nlm.nih.gov/pubmed/36387254
http://dx.doi.org/10.3389/fonc.2022.997093
_version_ 1784826592986398720
author Dennis, Claude
Prince, David S.
Moayed-Alaei, Leila
Remash, Devika
Carr-Boyd, Emily
Bowen, David G.
Strasser, Simone I.
Crawford, Michael
Pulitano, Carlo
Kench, James
McCaughan, Geoffrey W.
McKenzie, Catriona
Liu, Ken
author_facet Dennis, Claude
Prince, David S.
Moayed-Alaei, Leila
Remash, Devika
Carr-Boyd, Emily
Bowen, David G.
Strasser, Simone I.
Crawford, Michael
Pulitano, Carlo
Kench, James
McCaughan, Geoffrey W.
McKenzie, Catriona
Liu, Ken
author_sort Dennis, Claude
collection PubMed
description BACKGROUND: Vessels that encapsulate tumor clusters (VETC) is a novel vascular pattern seen on hepatocellular carcinoma (HCC) histology which has been shown to independently predict tumor recurrence and survival after liver resection. Its prognostic value in HCC patients receiving liver transplantation (LT) is unclear. METHODS: We retrospectively studied consecutive adults who underwent deceased-donor LT with active HCC found on explant between 2010-2019. Tumor tissue was stained for CD34 and quantified for VETC. Primary and secondary endpoints were time to recurrence (TTR) and recurrence-free survival (RFS). RESULTS: During the study period, 158 patients received LT where HCC was present on explant. VETC pattern was seen in 76.5% of explants. Patients with VETC-positive tumors spent longer on the waitlist (6.4 vs. 4.1 months, P=0.048), had higher median tumor numbers (2 vs. 1, P=0.001) and larger tumor sizes (20mm vs. 13mm, P<0.001) on explant pathology compared to those with VETC-negative tumors. Correspondingly, VETC-positive patients were more likely to be outside of accepted LT criteria for HCC. After 56.4 months median follow-up, 8.2% of patients developed HCC recurrence post-LT. On multivariable Cox regression, presence of VETC pattern did not predict TTR or RFS. However, the number of VETC-positive tumors on explant was an independent predictor of TTR (hazard ratio [HR] 1.411, P=0.001) and RFS (HR 1.267, P=0.014) after adjusting for other significant variables. CONCLUSION: VETC pattern is commonly observed in HCC patients undergoing LT. The number of VETC-positive tumors, but not its presence, is an independent risk factor for TTR and RFS post-LT.
format Online
Article
Text
id pubmed-9643778
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96437782022-11-15 Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation Dennis, Claude Prince, David S. Moayed-Alaei, Leila Remash, Devika Carr-Boyd, Emily Bowen, David G. Strasser, Simone I. Crawford, Michael Pulitano, Carlo Kench, James McCaughan, Geoffrey W. McKenzie, Catriona Liu, Ken Front Oncol Oncology BACKGROUND: Vessels that encapsulate tumor clusters (VETC) is a novel vascular pattern seen on hepatocellular carcinoma (HCC) histology which has been shown to independently predict tumor recurrence and survival after liver resection. Its prognostic value in HCC patients receiving liver transplantation (LT) is unclear. METHODS: We retrospectively studied consecutive adults who underwent deceased-donor LT with active HCC found on explant between 2010-2019. Tumor tissue was stained for CD34 and quantified for VETC. Primary and secondary endpoints were time to recurrence (TTR) and recurrence-free survival (RFS). RESULTS: During the study period, 158 patients received LT where HCC was present on explant. VETC pattern was seen in 76.5% of explants. Patients with VETC-positive tumors spent longer on the waitlist (6.4 vs. 4.1 months, P=0.048), had higher median tumor numbers (2 vs. 1, P=0.001) and larger tumor sizes (20mm vs. 13mm, P<0.001) on explant pathology compared to those with VETC-negative tumors. Correspondingly, VETC-positive patients were more likely to be outside of accepted LT criteria for HCC. After 56.4 months median follow-up, 8.2% of patients developed HCC recurrence post-LT. On multivariable Cox regression, presence of VETC pattern did not predict TTR or RFS. However, the number of VETC-positive tumors on explant was an independent predictor of TTR (hazard ratio [HR] 1.411, P=0.001) and RFS (HR 1.267, P=0.014) after adjusting for other significant variables. CONCLUSION: VETC pattern is commonly observed in HCC patients undergoing LT. The number of VETC-positive tumors, but not its presence, is an independent risk factor for TTR and RFS post-LT. Frontiers Media S.A. 2022-10-26 /pmc/articles/PMC9643778/ /pubmed/36387254 http://dx.doi.org/10.3389/fonc.2022.997093 Text en Copyright © 2022 Dennis, Prince, Moayed-Alaei, Remash, Carr-Boyd, Bowen, Strasser, Crawford, Pulitano, Kench, McCaughan, McKenzie and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Dennis, Claude
Prince, David S.
Moayed-Alaei, Leila
Remash, Devika
Carr-Boyd, Emily
Bowen, David G.
Strasser, Simone I.
Crawford, Michael
Pulitano, Carlo
Kench, James
McCaughan, Geoffrey W.
McKenzie, Catriona
Liu, Ken
Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
title Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
title_full Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
title_fullStr Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
title_full_unstemmed Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
title_short Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
title_sort association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643778/
https://www.ncbi.nlm.nih.gov/pubmed/36387254
http://dx.doi.org/10.3389/fonc.2022.997093
work_keys_str_mv AT dennisclaude associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT princedavids associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT moayedalaeileila associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT remashdevika associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT carrboydemily associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT bowendavidg associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT strassersimonei associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT crawfordmichael associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT pulitanocarlo associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT kenchjames associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT mccaughangeoffreyw associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT mckenziecatriona associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation
AT liuken associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation